HelpLine 1-800-298-2436

$10.5 Million in Additional Funding for Lung Cancer Research Pending

Department of Defense Lung Cancer Research Program Funded for 7th Consecutive Year: Total reaching $90M

WASHINGTON, DC [June 11, 2014]—Today, Lung Cancer Alliance announced that an additional $10.5 million for lung cancer research was approved by the Appropriations Committee of the House of Representatives as part of the Department of Defense funding bill for the coming fiscal year (FY2015).

The  FY 2015 DOD appropriations bill still needs to be voted on by the full House and the Senate,  but the House Committee action yesterday signals the research program remains strongly endorsed.

The additional funding would bring the total to $89.5 million that LCA has been able to secure for lung cancer research over the past seven years through  DOD’s Congressional Directed Medical Research Program (CDMRP).

The Lung Cancer Research Program was formally established in 2009 following a meeting LCA President Laurie Fenton Ambrose and LCA Board members held with the then Chairman of the Defense Appropriations Subcommittee, the late John Murtha (D-PA).